Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan
Journal
Journal of cardiovascular pharmacology and therapeutics
Journal Volume
27
Date Issued
2022
Author(s)
Lin, Po-Lin
Lee, Ying-Hsiang
Liu, Lawrence Yu-Min
Tsai, Cheng-Ting
Yang, Ten-Fang
Chiou, Wei-Ru
Chang, Hung-Yu
Huang, Chun-Che
Abstract
Changes in QRS duration in patients with heart failure with reduced ejection fraction (HFrEF) after sacubitril/valsartan therapy is not fully understood. This study aimed to assess the association of duration of HFrEF diagnosis with electrocardiographic and echocardiographic outcomes between before and after sacubitril/valsartan.
Subjects
QRS duration; heart failure with reduced ejection fraction; left ventricular ejection fraction; sacubitril/valsartan
Publisher
SAGE PUBLICATIONS INC
Type
journal article